Overview

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Determine the safety and efficacy of MK-0431/ONO-5435 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
Phase:
Phase 3
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Treatments:
Sitagliptin Phosphate